Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Milestone Medical Inc. [Member]
Income (Loss) from Equity Method Investments		$ (525,938)		$ (976,099)
Milestone Education LLC [Member]
Income (Loss) from Equity Method Investments		(3,621)		(7,836)
Milestone China [Member]
Income (Loss) from Equity Method Investments	(57,882)	(160,654)	(222,719)	(63,979)
Product sales, net	2,371,710	1,766,759	5,836,196	4,536,963
Cost of products sold	789,801	570,729	2,157,990	1,503,877
Gross profit	1,581,909	1,196,030	3,678,206	3,033,086
Selling, general and administrative expenses	3,290,998	2,590,897	6,292,109	4,488,978
Research and development expenses	309,335	18,820	452,780	28,938
Total operating expenses	3,600,333	2,609,717	6,744,889	4,517,916
Loss from operations	(2,018,424)	(1,413,687)	(3,066,683)	(1,484,830)
Interest income	(1,004)	(1,130)	(1,936)	80
Total other expenses, net	(1,004)	(1,130)	(1,936)	80
Loss before provision for income tax and equity in net earnings of equity investments	(2,019,428)	(1,414,817)	(3,068,619)	(1,484,750)
Provision for income tax	(16,791)	(13,646)	(63,624)	(13,646)
Loss before equity in net earnings of equity investments	(2,036,219)	(1,428,463)	(3,132,243)	(1,498,396)
Income (Loss) from Equity Method Investments	(57,882)	(690,213)	(222,719)	(1,047,914)
Net Loss	(2,094,101)	(2,118,676)	(3,354,962)	(2,546,310)
Net loss attributable to noncontrolling interests	507,262	45,727	976,308	53,987
Net loss attributable to Milestone Scientific Inc.	$ (1,586,839)	$ (2,072,949)	$ (2,378,654)	$ (2,492,323)
Net loss per share applicable to common stockholders—
Basic (in dollars per share)	$ (0.06)	$ (0.09)	$ (0.10)	$ (0.11)
Diluted (in dollars per share)	$ (0.06)	$ (0.09)	$ (0.10)	$ (0.11)
Weighted average shares outstanding and to be issued—
Basic (in shares)	25,989,857	22,405,897	24,362,441	22,390,332
Diluted (in shares)	25,989,857	25,114,399	24,362,441	25,132,192